Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy

Thrombosis Research

Volumn 127, Issue 3, 2011, Pages 277-278

  Kotlín, Roman ^a   Zichová, Kateřina ^a   Suttnar, Jiří ^a   Reicheltová, Zuzana ^a   Salaj, Peter ^a   Hrachovinová, Ingrid ^a   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE AALPHA; FIBRINOPEPTIDE B; GESTAGEN; HEMOSTATIC AGENT; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BLOOD SAMPLING; CASE REPORT; CURETTAGE; DISEASE ASSOCIATION; DYSFIBRINOGENEMIA; FEMALE; HEMATOMA; HETEROZYGOTE; HUMAN; LETTER; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OBSTETRIC HEMORRHAGE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBIN TIME; UTERUS BLEEDING;

ADULT; AFIBRINOGENEMIA; FEMALE; FIBRINOPEPTIDE A; HEMORRHAGE; HUMANS; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 79951957103     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.11.003     Document Type: Letter

References (18)

1. Deering SH, Landy HJ, Tchabo N, Kessler C. Hypodysfibrinogenemia during pregnancy, labor, and delivery. Obstet Gynecol 2003;101:1092-4. (Pubitemid 36566388)
2. Hanss M, Biot F. A Database For Human Fibrinogen Variants. Ann NY Acad Sci 2001;936:89-90http://site.geht.org/pages/?page=40&idl=21 accessed June 28, 2010.
3. Rose T, Di Cera E. Three-dimensional modeling of thrombin-fibrinogen interaction. J Biol Chem 2002;277:18875-80. (Pubitemid 34952447)
4. The Universal Protein Resource, http://www.uniprot.org/uniprot/?query= FGA&sort=score, accessed June 29, 2010.
5. Kotlín R, Reicheltová Z, Suttnar J, Salaj P, Hrachovinová I, Riedel T, Malý M, Oravec M, Kvasnička J, Dyr JE. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo. J Thromb Thrombolysis 2010;30:311-8.
6. Clauss A. Gerinnungsphysiologische Schnell-methode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46.
7. Kotlín R, Sobotková A, Riedel T, Salaj P, Suttnar J, Reicheltová Z, Májek P, Khaznadar T, Dyr JE. Acquired Dysfibrinogenemia Secondary to Multiple Myeloma. Acta Haematol 2008;120:75-81.
8. Kotlín R, Reicheltová Z, Malý M, Suttnar J, Sobotková A, Salaj P, Hirmerová J, Riedel T, Dyr JE. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzeň. Thromb Haemost 2009;102:479-86.
9. Suttnar J, Dyr JE, Fořtová H, Pristach J. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov 1989;18:17-25. (Pubitemid 19069787)
10. Kotlín R, Sobotková A, Suttnar J, Salaj P, Walterová L, Riedel T, Reicheltová Z, Dyr JE. A novel fibrinogen variant - Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution. Eur J Haematol 2008;81:123-9. (Pubitemid 352019636)
11. Gaja A, Terasawa F, Okumuna N. Hereditární dysfibrinogenemie s Aa13Gly®Glu mutací. In: Malý M, Pecka J, editors. Trombóza a hemostáza. HK Credit: Hradec Králové; 2001. p. 114.
12. Asselta R, Duga S, Spena S, Santagostino E, Peyvandi F, Piseddu G, Targhetta R, Malcovati M, Mannucci PM, Tenchini ML. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen Aα-chain gene are not associated with the decay of the mutant mRNAs. Blood 2001;98:3685-92.
13. Ménaché D. Congenital fibrinogen abnormalities. Ann NY Acad Sci 1983;408:121-9.
14. Mathonnet F, Peltier JY, Detruit H, de Raucourt E, Alvarez JC, Mazmanian GM, de Mazancourt P. Fibrinogen Saint-Germain I: a case of the heterozygous AαGLY 12 -> VAL fibrinogen variant. Blood Coagul Fibrinolysis 2002;13:149-53.
15. Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, Šantrůček J, Klener P, Dyr JE. Fibrinogen Nový Jičín and Praha II: Cases of hereditary Aalpha 16 Arg->Cys and Aalpha 16 Arg->His dysfibrinogenemia. Thromb Res 2007;121:75-84.
16. Kotlín R, Blažek B, Suttnar J, Malý M, Kvasnička J, Dyr JE. Dysfibrinogenemia in childhood: Two cases of congenital dysfibrinogens. Blood Coagul Fibrinolysis 2010;21:640-8.
17. Soria J, Soria C, Samama M, Poirot E, Kling C. Fibrinogen Troyes - Fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Thromb Diath Haemorrh 1972;27:619-33.
18. Higgins DL, Shafer JA. Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue. J Biol Chem 1981;256:12013-7. (Pubitemid 12139994)